Publications

Variation in Trmt11 Gene as a Prognostic Marker in Advanced-Stage Castrate-Resistant Prostate Cancer (Crpc) Patients.

AuthID
P-00G-D37

Author(s)

Zhang, BYM

Riska, SM

Mahoney, DW

Teixeira Ribeiro, RJT

Medeiros, R

Monteiro, C

Cerhan, JR

Costello, BA

Dronca, RS

Quevedo, F

Pitot, HC

Moynihan, TJ

Mauricio, J

Fraga, AM

Calais Da Silva, FEC

Kochuparambil, ST

Kohli, M

Document Type

Abstract

Year published

2015

Published

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 33, Issue: 15, Pages: e16114-e16114 (1)

Conference

Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 29-JUN 02, 2015, Location: Chicago, IL, Sponsors: Amer Soc Clin Oncol

Indexing

Wos^®

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2015.33.15_suppl.e16114

Wos: WOS:000358036903279

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Variation in Trmt11 Gene as a Prognostic Marker in Advanced-Stage Castrate-Resistant Prostate Cancer (Crpc) Patients.

Useful Links

Get Help

Federated Authentication (Click on the image)

Variation in Trmt11 Gene as a Prognostic Marker in Advanced-Stage Castrate-Resistant Prostate Cancer (Crpc) Patients.

Useful Links

Get Help